Desiree R Azizoddin1, Meenakshi Jolly2, Shilpa Arora3, Edward Yelin4, Patricia Katz4. 1. Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. 2. Rush University Medical Center, Chicago, Illinois. 3. John H. Stroger Hospital, Chicago, Illinois. 4. University of San Francisco California.
Abstract
OBJECTIVE: Fatigue is common among individuals with systemic lupus erythematosus (SLE), but the causes are not well understood. Our objective was to examine perceived stress and depressive symptoms as predictors of fatigue in SLE. METHODS: Data from 2 years of the Lupus Outcomes Study (n = 650 patients), obtained through annual structured interviews, were used. Fatigue was measured with the Short Form 36 (SF-36) vitality scale along with a variety of self-report measures of disease, depression, and stress. Multivariate linear regression models examined predictors of changes in fatigue. Model 1 tested the association of time 1 (T1) depression with time 2 (T2) fatigue; model 2 added T1 perceived stress to model 1, and final models added T1-to-T2 decrease in stress. All analyses controlled for T1 fatigue, age, sex, self-report of fibromyalgia, pain, and SLE duration, activity, and damage. RESULTS: Mean ± SD age was 51 ± 12 years, 92% of participants were women, and 68% were white. The mean ± SD SF-36 fatigue score was 55 ± 24. T1 depression significantly predicted T2 fatigue. When T1 stress was added, stress (β = 1.7 [95% confidence interval (95% CI) 1.1, 2.2]; P < 0.0001) significantly predicted T2 fatigue, but depression was no longer significant. The addition of T1-to-T2 decrease in stress was associated with a clinically meaningful decline in fatigue (β = -11.8 [95% CI -15.6, -8.9]; P < 0.0001). CONCLUSION: While depressive symptoms initially predicted subsequent fatigue, the effects were mediated by stress. A decrease in stress, in addition, was associated with a clinically meaningful decrease in fatigue. These results suggest that perceived stress plays an important role in SLE fatigue and may be an important focus of interventions for fatigue.
OBJECTIVE:Fatigue is common among individuals with systemic lupus erythematosus (SLE), but the causes are not well understood. Our objective was to examine perceived stress and depressive symptoms as predictors of fatigue in SLE. METHODS: Data from 2 years of the Lupus Outcomes Study (n = 650 patients), obtained through annual structured interviews, were used. Fatigue was measured with the Short Form 36 (SF-36) vitality scale along with a variety of self-report measures of disease, depression, and stress. Multivariate linear regression models examined predictors of changes in fatigue. Model 1 tested the association of time 1 (T1) depression with time 2 (T2) fatigue; model 2 added T1 perceived stress to model 1, and final models added T1-to-T2 decrease in stress. All analyses controlled for T1 fatigue, age, sex, self-report of fibromyalgia, pain, and SLE duration, activity, and damage. RESULTS: Mean ± SD age was 51 ± 12 years, 92% of participants were women, and 68% were white. The mean ± SD SF-36 fatigue score was 55 ± 24. T1 depression significantly predicted T2 fatigue. When T1 stress was added, stress (β = 1.7 [95% confidence interval (95% CI) 1.1, 2.2]; P < 0.0001) significantly predicted T2 fatigue, but depression was no longer significant. The addition of T1-to-T2 decrease in stress was associated with a clinically meaningful decline in fatigue (β = -11.8 [95% CI -15.6, -8.9]; P < 0.0001). CONCLUSION: While depressive symptoms initially predicted subsequent fatigue, the effects were mediated by stress. A decrease in stress, in addition, was associated with a clinically meaningful decrease in fatigue. These results suggest that perceived stress plays an important role in SLE fatigue and may be an important focus of interventions for fatigue.
Authors: Deborah Da Costa; Maria Dritsa; Sasha Bernatsky; Christian Pineau; Henri A Ménard; Kaberi Dasgupta; Anahita Keschani; Natalie Rippen; Ann E Clarke Journal: J Rheumatol Date: 2006-06-01 Impact factor: 4.666
Authors: Kathleen McElhone; Madhura Castelino; Janice Abbott; Ian N Bruce; Yasmeen Ahmad; Joanna Shelmerdine; Kate Peers; David Isenberg; Ada Ferenkeh-Koroma; Bridget Griffiths; Mohammed Akil; Peter Maddison; Caroline Gordon; Lee-Suan Teh Journal: J Rheumatol Date: 2010-09-01 Impact factor: 4.666
Authors: Tamara J Somers; Preethi C Kurakula; Lisa Criscione-Schreiber; Francis J Keefe; Megan E B Clowse Journal: Arthritis Care Res (Hoboken) Date: 2012-09 Impact factor: 4.794
Authors: N Navarrete-Navarrete; M I Peralta-Ramírez; J M Sabio; I Martínez-Egea; A Santos-Ruiz; J Jiménez-Alonso Journal: Lupus Date: 2010-09-14 Impact factor: 2.911
Authors: Stacey L Hart; Michael A Hoyt; Michael Diefenbach; Derek R Anderson; Kristin M Kilbourn; Lynette L Craft; Jennifer L Steel; Pim Cuijpers; David C Mohr; Mark Berendsen; Bonnie Spring; Annette L Stanton Journal: J Natl Cancer Inst Date: 2012-07-05 Impact factor: 13.506
Authors: Sara S McCoy; Miguel Woodham; Christie M Bartels; Ian J Saldanha; Vatinee Y Bunya; Noah Maerz; Esen K Akpek; Matthew A Makara; Alan N Baer Journal: Arthritis Rheumatol Date: 2022-08-03 Impact factor: 15.483
Authors: Marta Jaskólska; Magdalena Chylińska; Anna Masiak; Katarzyna Nowicka-Sauer; Mariusz Siemiński; Marcin Ziętkiewicz; Zenobia Czuszyńska; Zbigniew Zdrojewski Journal: Rheumatol Int Date: 2020-03-14 Impact factor: 2.631